339 related articles for article (PubMed ID: 10688905)
1. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.
Nebigil CG; Launay JM; Hickel P; Tournois C; Maroteaux L
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2591-6. PubMed ID: 10688905
[TBL] [Abstract][Full Text] [Related]
2. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
4. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
5. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
Sinibaldi D; Wharton W; Turkson J; Bowman T; Pledger WJ; Jove R
Oncogene; 2000 Nov; 19(48):5419-27. PubMed ID: 11114718
[TBL] [Abstract][Full Text] [Related]
6. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
7. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
9. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
[TBL] [Abstract][Full Text] [Related]
10. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
11. CCK(B)/gastrin receptor mediates synergistic stimulation of DNA synthesis and cyclin D1, D3, and E expression in Swiss 3T3 cells.
Zhukova E; Sinnett-Smith J; Wong H; Chiu T; Rozengurt E
J Cell Physiol; 2001 Dec; 189(3):291-305. PubMed ID: 11748587
[TBL] [Abstract][Full Text] [Related]
12. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor.
Gao Y; Tang S; Zhou S; Ware JA
J Pharmacol Exp Ther; 2001 Feb; 296(2):426-33. PubMed ID: 11160627
[TBL] [Abstract][Full Text] [Related]
13. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression.
Boonyaratanakornkit V; Bi Y; Rudd M; Edwards DP
Steroids; 2008 Oct; 73(9-10):922-8. PubMed ID: 18321550
[TBL] [Abstract][Full Text] [Related]
14. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
15. c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells.
Choudhury GG; Mahimainathan L; Das F; Venkatesan B; Ghosh-Choudhury N
Cell Signal; 2006 Nov; 18(11):1854-64. PubMed ID: 16530387
[TBL] [Abstract][Full Text] [Related]
16. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway.
Tashiro E; Maruki H; Minato Y; Doki Y; Weinstein IB; Imoto M
Cancer Res; 2003 Jan; 63(2):424-31. PubMed ID: 12543798
[TBL] [Abstract][Full Text] [Related]
18. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle signaling by endothelin-1 requires Src nonreceptor protein tyrosine kinase.
Mishra R; Wang Y; Simonson MS
Mol Pharmacol; 2005 Jun; 67(6):2049-56. PubMed ID: 15772290
[TBL] [Abstract][Full Text] [Related]
20. RACK1 regulates G1/S progression by suppressing Src kinase activity.
Mamidipudi V; Zhang J; Lee KC; Cartwright CA
Mol Cell Biol; 2004 Aug; 24(15):6788-98. PubMed ID: 15254245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]